M&A

Asia: Healthcare's Biggest M&A Opportunity And Challenge
Forbes
Thu, 09/19/13 - 11:05 am
M&A
Asia
Analyst Sees Big Risks Lurking in Possible Biotech Buyout
Yahoo/24-7 Wall St
Wed, 09/18/13 - 12:44 pm
ViroPharma
Sanofi
M&A
Shire
Clovis Oncology Said to Explore Sale of Biotech Company
Bloomberg
Tue, 09/17/13 - 04:37 pm
Clovis Oncology
M&A
Italy's Chiesi to buy rest of Cornerstone Therapeutics
Reuters
Mon, 09/16/13 - 03:45 pm
Italy
M&A
Cornerstone Therapeutics
Chiesi
ViroPharma Skyrockets on Buyout Rumors
equities.com
Sat, 09/14/13 - 11:13 am
ViroPharma
M&A
Astex Sued by Shareholder Over $886 Million Otsuka Bid
Bloomberg
Fri, 09/13/13 - 03:44 pm
Astex
shareholders
Otsuka
M&A
Pharma chief casts doubt on Roche interest in Alexion
Fierce Pharma
Thu, 09/12/13 - 10:30 am
Alexion
Roche
M&A
Daniel O'Day
Why Sangamo Was Smart To Buy Ceregene
TheStreet.com
Thu, 09/12/13 - 10:19 am
Sangamo
Ceregene
M&A
Baxter makes a smaller buy with $9.5M acquisition of Minn.-based FlowSense
Mass Device
Wed, 09/11/13 - 09:54 am
M&A
FlowSense
Baxter
devices
Is Seattle Genetics an Acquisition Target?
Motley Fool
Tue, 09/10/13 - 10:26 am
M&A
Seattle Genetics
Adcetris
Bayer
AbbVie
Genentech
Baxter and Gambro seal the deal on $3.9B acquisition
Mass Device
Mon, 09/9/13 - 10:39 am
Baxter International
Gambro
M&A
devices
Glaxo to Sell Drink Brands for $2.1 Billion
NY Times, NY
Mon, 09/9/13 - 09:21 am
M&A
GSK
Japan
Cadila Health, Torrent Pharma mulling merger: Sources
Economic Times, India
Sun, 09/8/13 - 11:11 am
Cadila
Torrent Pharmaceuticals
M&A
Johnson & Johnson reportedly eyes sale of clinical diagnostics unit
MarketWatch
Sat, 09/7/13 - 12:02 pm
JNJ
Ortho Clinical Diagnostics
M&A
Onyx Sued by Investors Claiming Amgen Buyout Is Too Cheap
Bloomberg
Sat, 09/7/13 - 11:44 am
ONYX Pharmaceutical
Amgen
M&A
lawsuits
KKR favoured in $1.5 bln Panasonic healthcare talks -sources
Reuters
Fri, 09/6/13 - 10:49 am
KKR
M&A
devices
Panasonic
Japan's Otsuka to buy Astex Pharma for about $900 million
Reuters
Wed, 09/4/13 - 05:33 pm
Japan
M&A
Otsuka
Astex
Amgen With Onyx Pharmaceuticals: Long-Term Analysis
Seeking Alpha
Wed, 09/4/13 - 01:15 pm
Amgen
ONYX Pharmaceuticals
M&A
Medical device co C. R. Bard to buy peer Rochester Medical for $262 mln
Reuters
Wed, 09/4/13 - 11:14 am
CR Bard
M&A
Rochester Medical
devices
Are Biotech M&A Premiums Already Built In? Valuations Do Matter
Seeking Alpha
Tue, 09/3/13 - 04:19 pm
biotech
M&A
ONYX Pharmaceuticals
Alexion
Biomarin
Incyte
Medivation
Pharmacyclics
Regeneron
Seattle Genetics

Pages